| DO2 | LOF | TropT guided | |||
---|---|---|---|---|---|---|
Age (years) | 59 (37-73) | Â | 52 (18-76) | Â | 64 (54-75) | Â |
ICU-stay (days) | 16 (2-67) | Â | 17(3-38) | Â | *12(4-36) | Â |
Mortality | 8/10 | Â | 4/10 | Â | 5/10 | Â |
 | Baseline | Max | Baseline | Max | Baseline | Max |
APACHE III | 66 (48-85) | 98 (85-116) | 64 (31-105) | 80(43-124) | 63 (38-97) | 95(59-100) |
ST-SD (mV) | 0.0 | 1.0 | 0.0 | 0.3 | 0.0 | 0.5 |
 | (0.0-1.4) | (0.4-2.8) | (0.0-1.7) | (0.0-1.8) | (0.0-1.5) | (0.0-1.5) |
TropT (ng/ml) | 0.07 | *0.43 | 0.17 | *0.30 | 0.08 | *0.12 |
 | (0.05-0.16) | (0.11-7.82) | (0.03-5.93) | (0.06-10.79) | (0.02-0.16) | (0.03-0.17) |
TEE (H/D/A) | 86/18/5 | Â | 51/4/2 | Â | 42/3/1 | Â |